Hemophilia Federation of America/LinkedIn
Mar 28, 2026, 19:02
Marking a Century of Progress in von Willebrand Disease – HFA
Hemophilia Federation of America (HFA) posted on LinkedIn:
”This year marks 100 years since Finnish physician Erik von Willebrand first described von Willebrand disease (vWD), the most common inherited bleeding disorder.
As we reflect on a century of progress, continued education and patient-centered insights remain essential to improving outcomes.
At Symposium New Orleans, HFA will feature sessions focused on vWD, including:
- ‘Understanding Your vWD Type: What It Means for You Across the Lifespan,’ featuring Nicoletta C. Machin.
- ‘Listening to People with von Willebrand Disease and Their Caregivers: Insights from the PIVOT-vWD US Patient-Reported Evidence and Insights Program’ featuring Sam Bristow, Co-founder and CEO of DHT Health
Register to join the conversation.”

Hemophilia Federation of America/LinkedIn
Keep up with Hemostasis Today.
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders
-
Nov 18, 2026, 13:19Sjoerd Fabian Koopman: Exploring Tissue Distribution of Extended Half-Life Factor IX Concentrates
-
Nov 18, 2026, 13:16Ifeanyichukwu Ifechidere: Choosing Between Clot-Based and Chromogenic Coagulation Assays